相关实验视频

Updated: Jan 9, 2026

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

胺β修改了人体红细胞的膜结构和表面静电特性

Galya Staneva^1,2, Vesela Yordanova^1,2, Avgustina Danailova¹

¹Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, "Acad. G. Bonchev" Str., Block 21, 1113 Sofia, Bulgaria.

International journal of molecular sciences

|December 11, 2025

概括

阿尔茨海默病 (AD) 涉及粉样β (Aβ) 影响大脑细胞. 这项研究表明,Aβ42还改变红细胞 (RBC) 的物理特性,可能影响系统性AD效应.

科学领域:

神经科学是一个神经科学.
生物化学生物化学
细胞生物学细胞生物学

背景情况:

阿尔茨海默病 (AD) 的特点是大脑中粉样β (Aβ) 积累.
周围血液细胞,包括红细胞 (RBC),也暴露于Aβ.
了解Aβ与红细胞等非神经元细胞的相互作用,对于理解AD的系统影响至关重要.

研究的目的:

作为阿尔茨海默病的体外模型,研究粉样β 42 (Aβ42) 寡合体和人类红细胞 (RBC) 之间的相互作用.
分析Aβ42对红细胞膜物理性能的影响,包括脂质顺序和表面潜力.
为了比较Aβ42对完整红细胞和红细胞幽灵细胞的影响.

主要方法:

使用光谱和显微镜可视化和量化Aβ42与红细胞的结合.
评估了红细胞膜脂质顺序的变化.
使用电动力学测量 (ζ-电位) 来评估红细胞表面电荷的变化.

主要成果:

光标记的Aβ42被证明与红细胞结合.
Aβ42以度和时间依赖的方式增加了红细胞膜脂质顺序.
Aβ42显著改变了红细胞的表面潜力 (ζ-潜力),使其更为负.

结论:

胺β 42 (Aβ42) 显著改变红细胞 (RBC) 的物理特性.
这些红细胞的变化,包括增加的脂质顺序和修改的表面潜力,可能会损害它们的功能.
这些发现表明,Aβ42的影响超出了大脑范围,可能导致阿尔茨海默病的系统性影响.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.氨基βββββββββββββββββββββββββ 同焦点显微镜的共焦显微镜.膜脂质的顺序膜脂质的顺序红细胞是血液中的红细胞.ζ-潜在的可能.

更多相关视频

Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids

Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids

Published on: March 21, 2025

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation

Published on: March 27, 2017

相关概念视频

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Amyloid Fibrils

Amyloid Fibrils

Protein Modifications in the RER

Protein Modifications in the RER

Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...